Skip to main content
# Title Department Research Year
51 Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists Department of Pharmaceutical Organic Chemistry 2024
52 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
53 Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024
54 Dual emission BSA-capped bimetallic nanoclusters for detection of acrylamide in certain food matrices based on thiol-ene Michael addition click reaction Department of Pharmaceutical Analytical Chemistry 2024
55 Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review Department of Microbiology and Immunology 2024
56 Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities Department of Medicinal Chemistry 2024
57 Developing a switch “OFF-ON” fluorescent probe for detection of melamine based on doubly-protected red emissive copper nanoclusters mediated by Hg2+ ions Department of Pharmaceutical Analytical Chemistry 2024
58 Highly selective fluorometric detection of streptokinase via fibrinolytic release of photoluminescent carbon dots integrated into fibrin clot network Department of Pharmaceutical Analytical Chemistry 2024
59 Design and synthesis new dihydropyrimidine derivatives with cytotoxic effect as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
60 Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024